Postoperative adjuvant TACE combined with lenvatinib and immune checkpoint inhibitors for hepatocellular carcinoma with high recurrence risks: a multicenter retrospective study.

ABSTRACT:

SUBMITTER: Huang Z 

PROVIDER: S-EPMC12903653 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature